Nordic Pharma Lab ApS
CVR 39161672 · Private limited company (ApS) · Active · Medium risk
Nordic Pharma Lab ApS is a Private limited company (ApS), founded on , based in Hørsholm. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 1.8% over the next 12 months, which is 1.3 times the average for Danish companies. 8 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -429k and a net result of DKK -111k. CEO: Torsten Bjørn.
Bankruptcy risk for Nordic Pharma Lab ApS
1.3 × the average (1.41%) · higher risk than 81% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 39161672
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (8 years)
- Address
- Slotsmarken 12, 1. th
2970 Hørsholm - Municipality
- Hørsholm
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 100k
- Auditor
- Grant Thornton, Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 2 of 8 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -2,829.6% |
| Current ratio | 3% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 1 |
| Other companies at the address | 58 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -52k | DKK -19k |
| Net profit | DKK -111k | DKK -31k |
| Equity | DKK -429k | DKK -319k |
| Total assets | DKK 15k | DKK 5,000 |
| Cash | DKK 11k | – |
| Short-term debt | DKK 445k | – |
| Avg. employees | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Grant Thornton, Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 147 | ||
| 1 Jan 2024 – 31 Dec 2024 | 146 | ||
| 1 Jan 2023 – 31 Dec 2023 | 182 | ||
| 1 Jan 2022 – 31 Dec 2022 | 184 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 157 | ||
| 1 Jan 2020 – 31 Dec 2020 | 194 | Late | |
| 1 Jan 2019 – 31 Dec 2019 | 181 | ||
| 10 Dec 2017 – 31 Dec 2018 | 155 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Torsten Bjørn | Current | |
| CEO | Peter Andreas Stakemann | ||
| Owner (5%) | VULKAN INVEST ApS | Current | |
| Owner (5%) | TT 1919 ApS | Current | |
| Owner (20%) | Beier Holding ApS | Current | |
| Owner (50%) | FINANSMANAGEMENT ApS | Current | |
| Owner (100%) | ApS KBURS 17 NR. 6919 | ||
| Owner (100%) | FINANSMANAGEMENT ApS | ||
| Owner (10%) | PM Group Holding ApS | ||
| Owner (33%) | FINANSMANAGEMENT ApS | ||
| Auditor | Grant Thornton, Godkendt Revisionspartnerselskab | Current | |
| Founder | ApS KBURS 17 NR. 6919 | Current |
The CEOs' other companies
Torsten Bjørn – 21 other companies, of which 2 bankrupt
- NATURAL MEDICO TECH ApS Bankrupt 26 Nov 2010
- VICH 3955 ApS Bankrupt 17 Oct 1996
- AKI Therapeutics A/S Active
- AQUA-WALL DANMARK A/S Fusioneret
- BIOPORTO DIAGNOSTICS A/S Active
- DKA CONSULT ApS Opløst
- DKA EJENDOMME ApS Opløst
- Geysir Holding ApS Active
- Geysir Invest ApS Active
- NORDIC BIOTECH HOLDING ApS Active
- Nordic Science Group ApS Active
- REPOCEUTICALS A/S Active
- REPONEX PHARMACEUTICALS A/S Active
- REPOS PHARMA ApS Opløst
- SAX FINANS ApS Active
- SCHWANEBECK VERWALTUNG ZWEI ApS Opløst
- SPONSOR SUPPORT ApS Compulsorily dissolved
- SPRINGE/GESTORF VERWALTUNG ApS Active
- Serenova A/S Opløst
- VICTOR & FABIAN ApS Compulsorily dissolved
- VULKAN INVEST ApS Active
Peter Andreas Stakemann – 54 other companies, of which 54 bankrupt
- 01-05-24 ApS Bankrupt 17 Mar 2025
- 061746M A/S Bankrupt 3 Oct 2011
- 1 STEP, COPENHAGEN LOGISTIC & DISTRIBUTION ApS Bankrupt 15 Jan 2009
- 1001 WATT ApS Bankrupt 29 Jan 2002
- 123 AF 04.07.2012 ApS Bankrupt 6 Aug 2012
- 1264 ApS Bankrupt 12 Jun 2012
- 1414 EJENDOMSINVEST 10 ApS Bankrupt 22 Dec 2015
- 1414 EJENDOMSINVEST 12 ApS Bankrupt 22 Dec 2015
- 1414 EJENDOMSINVEST ApS Bankrupt 19 Dec 2014
- 1414 INVEST ApS Bankrupt 22 Dec 2015
- 1WAY2PRINT A/S Bankrupt 24 Jul 2003
- 2 X KJAER DK ApS Bankrupt 18 Dec 2024
- 20220608 ApS Bankrupt 18 Jul 2022
- 23K ApS Bankrupt 17 Jan 2022
- 24237982 A/S Bankrupt 25 Apr 2012
- 2BU EJENDOMME ApS Bankrupt 11 Sep 2013
- 2BU HOLDING ApS Bankrupt 2 Oct 2013
- 2Tal enterprise A/S Bankrupt 28 Apr 2020
- 2V AMAGER SYD ApS Bankrupt 20 Dec 2000
- 3 SIGMA ApS Bankrupt 9 Jun 2005
- 30 08 61 71 ApS Bankrupt 1 Dec 2011
- 31. OKTOBER 2008 ApS Bankrupt 18 Sep 2009
- 32 67 71 93 ApS Bankrupt 16 Nov 2011
- 36087374 ApS Bankrupt 10 Jan 2017
- 365 Service Holding ApS Bankrupt 26 Nov 2020
- 365 Service Partner ApS Bankrupt 26 Nov 2020
- 39701804 ApS Bankrupt 14 Aug 2020
- 39704994 ApS Bankrupt 14 Aug 2020
- 3BH ApS Bankrupt 3 May 2019
- 3XE BYG ApS Bankrupt 11 Aug 2017
Address history (1 moves)
| Slotsmarken 12, 1. th, 2970 Hørsholm | |
| Kronprinsessegade 18, 1306 København K |
Former names
| Nordic Pharma Lab ApS | – now |
| ApS STM nr. 6145 | – |
Other companies at the same address
- CVIP ApS Bankrupt
- CVIP HOLDING ApS Bankrupt
- HI AF 26/11-2010 A/S Bankrupt
- Liquid Wind Denmark ApS Bankrupt
- A/S CRYSTINOL Fusioneret
- AKI Therapeutics A/S Active
- ApS KBUS 17 NR. 4807 Opløst
- ApS KBUS 38 NR. 1027 Opløst
- Aurea Kapital ApS Active
- BIOPHARMA HOLDING ApS Opløst
- BLANKAMI ApS Opløst
- CAMBRIDGE TECHNOLOGY PARTNERS A/S Opløst
- DKA ADMINISTRATION ApS Opløst
- DKA CONSULT ApS Opløst
- DKA EJENDOMME ApS Opløst
- DKA FINANS ApS Opløst
- DKA INVEST ApS Opløst
- EXPANDIT DEVELOPMENT ApS Active
- EXPANDIT HOLDING A/S Active
- EXPANDIT INTERNATIONAL A/S Active
- EXPANDIT MOBILE ApS Active
- EXPANDIT UTILITIES ApS Opløst
- Erestas ApS Active
- FACET 4 ApS Compulsorily dissolved
- FINANSMANAGEMENT 2 ApS Opløst
Similar companies in Hørsholm
- PeriOp Innovations ApS Hørsholm
- Nordic Science Group ApS Hørsholm
- Afyx Therapeutics A/S Hørsholm
- AKI Therapeutics A/S Hørsholm
- REPOCEUTICALS A/S Hørsholm
- CONRIG PHARMA ApS Vedbæk
- REPONEX PHARMACEUTICALS A/S Hørsholm
- RB af 31-5-2018 ApS Hørsholm
- Netto Medicin IVS Rungsted Kyst
- Footprint Pharma ApS Hørsholm
- REPOS PHARMA ApS Hørsholm
Questions and answers about Nordic Pharma Lab ApS
Has Nordic Pharma Lab ApS gone bankrupt?
No, Nordic Pharma Lab ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Nordic Pharma Lab ApS?
Our model estimates a bankruptcy risk of 1.8% over the next 12 months (medium risk), which is 1.3 times the average for Danish companies.
Who is the CEO of Nordic Pharma Lab ApS?
Torsten Bjørn is the CEO of Nordic Pharma Lab ApS.
Who is the auditor of Nordic Pharma Lab ApS?
Nordic Pharma Lab ApS most recently used Grant Thornton, Godkendt Revisionspartnerselskab.
When was Nordic Pharma Lab ApS founded?
Nordic Pharma Lab ApS was founded on 10 December 2017.
What is the equity of Nordic Pharma Lab ApS?
Equity was DKK -429k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.